Insulin-like growth factor I circumvents defective insulin action in human myotonic dystrophy skeletal muscle cells

Endocrinology

Volumn 140, Issue 9, 1999, Pages 4244-4250

  Furling, Denis ^a   Marette, André ^b   Puymirat, Jack ^a,b  

^a University Hospital Center of Québec ^*  (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; MESSENGER RNA; PROTEIN SERINE THREONINE KINASE; SOMATOMEDIN C; TRINUCLEOTIDE;

ARTICLE; BINDING AFFINITY; CELL CULTURE; DISEASE SEVERITY; FETUS; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; MUSCLE ATROPHY; MUSCLE WEAKNESS; MYOTONIC DYSTROPHY; MYOTUBE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SOUTHERN BLOTTING; TRINUCLEOTIDE REPEAT; WESTERN BLOTTING;

EID: 0033305021     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.9.7057     Document Type: Article

References (48)

1. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member
2. An unstable triplet repeat in a gene related to myotonic muscular dystrophy
3. Myotonic dystrophy mutation: An unstable CTG repeat in the 3' untranslated region of the gene
4. Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts
5. Triplet-repeat transcripts: A role for RNA in disease
6. Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes
7. Studies of plasma insulin in myotonic dystrophy
8. Abnormal insulin secretion in myotonic dystrophy
9. Abnormalities of insulin secretion in dystrophia myotonica
10. Decreased insulin sensitivity of forearm muscle in myotonic dystrophy
11. Decreased cerebral glucose utilization in myotonic dystrophy
12. Correlation between decreased myocardial glucose phosphorylation and DNA mutation size in myotonic dystrophy
13. Whole body insulin resistance in myotonic dystrophy
14. Muscle insulin resistance in myotonic dystrophy: Effect of supraphysiologic insulinization
15. Studies on insulin resistance and insulin receptor binding in myotonia dystrophica
16. RNA metabolism in myotonic dystrophy: Patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance
17. The role of insulin resistance in the pathogenesis of myotonic muscular dystrophy
18. Binding activity and autophosphorylation of the insulin receptor from patients with myotonic dystrophy
19. In vivo estimation of muscle protein synthesis in myotonic dystrophy
20. Mechanism of muscle wasting in myotonic dystrophy
21. Insulin-like growth factors and insulin: Comparative aspects
22. Molecular and cellular aspects of the insulin-like growth factor I receptor
23. Characterization of insulin-like growth factor receptor (IGF) I in skeletal mescles of normal and insulin resistant subjects
24. Insulin and IGF-I induce pronouced hypertrophy of skeletal myofibers in tissu culture
25. Metabolic and clinical responsr to recombinant human insulin-like growth fator I in myotonic dystrophy - A clinical research center study
26. Effect of insulin-like growth factor I in murine muscular dystrophy
27. Increase in the proliferative capacity of human myoblasts by using the T antigen under the vimentin promoter control
28. Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin
29. A rapid and sensitive method for the quantitation of microgram quantifies of protein utilizing the principle of protein binding
30. Transient exposure of human myoblasts to tumor necrosis factor-α inhibits serum and insulin-like growth factor-I stimulated protein synthesis
31. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
32. Human primary myoblast cell cultures from non-diabetic insulin resistant subjects retain defects in insulin action
33. Glucose uptake in human and animal muscle cells in culture
34. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects: Comparison using human skeletal muscle cell cultures
35. Insulin and insulin-like growth factor receptors and responses in cultured human muscle cells
36. Characterization of insulin-like growth factor I receptor in skeletal muscle of normal and insulin resistant subjects
37. Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells
38. Abnormal regulation of monocyte insulin-binding affinity after glucose ingestion in patients with myotonic dystrophy
39. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues
40. Identification of a (CUG) triplet RNA-binding protein and its expression in myotonic dystrophy
41. Altered phosphorylation and intracellular distribution of a (CUG)n triplet tepeat RNA-binding protein in patients with myotonic dystrophy and in myotonic protein kinase knockout mice
42. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy
43. The insulin signaling system and the IRS proteins
44. From receptor to transporter: Insulin signalling to glucose transport
45. A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes
46. Comparative effects of CTG gamma S and insulin on the activation of Rho, phosphatidylinositol 3-kinase, and protein kinase N in rat adipocytes-relationship to glucose transport
47. Characterization of the intracellular signalling pathways that underlie growth-factor-stimulated glucose transport in Xenopus oocytes: Evidence for Ras- and Rho-dependent pathways of phosphatidylinositol 3-kinase activation